2024/09/26
Application of Tau PFFs and Alpha-Synuclein PFFs in Neurodegenerative Disease Research
This study explores the application of tau and α-synuclein pre-formed fibrils (PFFs) in neurodegenerative disease research. By inducing protein aggregation, PFFs effectively model the progression of diseases like Alzheimer′s disease and Parkinson disease, offering valuable tools for drug discovery.
더 보기
2024/09/13
Tecelra® Approval Marks Milestone in Solid Tumor Immunotherapy: Advancing TCR-T Cell Therapy
The landscape of cancer immunotherapy has witnessed a significant breakthrough with the FDA's recent approval of Tecelra ® (Afamitrisgene autoleucel,Afami-cel), developed by Adaptimmune Therapeutics. This approval marks the first T-cell receptor (TCR) therapy for solid tumors, specifically targeting
더 보기
2024/07/18
ACROBiosystems Launches GMP Brand Resilient Supply at ISSCR to Accelerate Cell and Gene Therapy Development
At the recent International Society for Stem Cell Research (ISSCR) Annual Meeting in Hamburg, ACROBiosystems announced its new GMP-centered brand, Resilient Supply, with the mission of accelerating the advancement of cell and gene therapy (CGT) development.
더 보기
2024/10/10 - 2024/10/10
Challenges and Strategies in Method Development for Vaccine Efficacy Evaluation
Speaker: ACROBiosystems
Time: 2024.10.10 October 10th 12:00 CET, SGT 18:00, KST/JST 19:00, IST 15:30
더 보기
Leave a like or
share your feedback!
6809